Blog Archives

Demonstrating Progress: Building a More Equitable Global R&D System

By PLOS Guest Blogger
Posted: May 24, 2013
Category: Access, Neglected Diseases | Tagged , , , , | Leave a comment

From What We Know to What We Do: Now is the Time for Governments to Fix a Failing System for Drug Development

By PLOS Guest Blogger
Posted: May 15, 2013
Category: Neglected Diseases | Tagged , , , , , , , | Leave a comment

European Court is on the Wrong Side on Patient Safety

By PLOS Guest Blogger
Posted: May 1, 2013
Category: Access, General | Tagged , , , , | Leave a comment

Vaccines in Developing Countries: Why the High Prices?

By Médecins Sans Frontières
Posted: April 23, 2013
Category: PLoS | Tagged , , , , , | Leave a comment

Anyone for an Evidence Summer?

By Virginia Barbour
Posted: April 17, 2013
Category: Conference news, Evidence, General, Public | Tagged , , | Leave a comment

(B)3-Bad Science, Bad Pharma…now Bad Guidelines

By Virginia Barbour
Posted: February 4, 2013
Category: Access, General | Tagged , , , , , , , , | Leave a comment

Getting serious about registering and reporting trials – alltrials.net

By Virginia Barbour
Posted: January 18, 2013
Category: Access, General | Tagged , , , , , , | Leave a comment

Now is the time for transparency and access to clinical-trial data

By PLOS Guest Blogger
Posted: December 7, 2012
Category: Access | Tagged , , , , , , , , , | Leave a comment

India’s patent law on trial

By Médecins Sans Frontières
Posted: October 1, 2012
Category: General | Tagged , , , , | Leave a comment

Industry’s Influence

By Jessica Wapner
Posted: September 20, 2012
Category: Drug Development, Housekeeping, Industry funding | Tagged , , , , , , , | Leave a comment